NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults7 Aug 2026
Jupiter Life Line Hospitals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has announced its Q1 FY27 earnings, with total income at INR411 crores, EBITDA at INR79.3 crores, and PAT at INR37.5 crores. The company's Dombivli Hospital has completed its first full quarter of operations, contributing to a INR9.5 crores drag on EBITDA. The other 3 operating hospitals and 3 upcoming projects are progressing on track.
NSECopy of Newspaper PublicationResults3 Aug 2026
Jupiter Life Line Hospitals Limited
Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults3 Aug 2026
Jupiter Life Line Hospitals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has informed the Exchange about the link to the recording of the Analyst/Investor Conference Call for Q1 FY27.
NSEGeneral UpdatesgovernanceConcern31 Jul 2026
Jupiter Life Line Hospitals Limited
General Updates
Jupiter Life Line Hospitals Limited has intimated under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015, that the Board of Directors has authorized Mr. Harshad Purani, Chief Financial Officer, and Dr. Ankit Thakker, Managing Director and Chief Executive Officer, to determine the materiality of events or information, and Ms. Suma Upparatti, Company Secretary and Compliance Officer, to make disclosures to the Stock Exchange(s).
NSEInvestor PresentationResults31 Jul 2026
Jupiter Life Line Hospitals Limited
Investor Presentation
Jupiter Life Line Hospitals Limited has released its Q1FY27 financial results, showing a total income of Rs 411.0 cr, EBITDA of Rs 78.4 cr, PBT of Rs 79.3 cr, and PAT of Rs 61.7 cr. The company's Dombivli hospital has completed its first full quarter of operations, with occupancy increasing steadily due to growing patient footfall and expansion of clinical services.
NSEAdoption of new line(s) of businessExpansion31 Jul 2026
Jupiter Life Line Hospitals Limited
Adoption of new line(s) of business
Jupiter Life Line Hospitals Limited has adopted a new line of business by acquiring 100% of the equity share capital of Sulcus Private Limited for ₹3.78 crore, and has also appointed a new Chief Financial Officer.
NSEOutcome of Board MeetingResults31 Jul 2026
Jupiter Life Line Hospitals Limited
Outcome of Board Meeting
Jupiter Life Line Hospitals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with the appointment of a new Chief Financial Officer and the acquisition of a subsidiary.
NSEAppointmentMgmt Change31 Jul 2026
Jupiter Life Line Hospitals Limited
Appointment
Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Purani as Chief Financial Officer (CFO) of the company, effective July 31, 2026. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and has acquired 100% of the equity share capital of Sulcus Private Limited.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults27 Jul 2026
Jupiter Life Line Hospitals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has informed the Exchange about the schedule of a meet to discuss the operational and financial performance for Q1 FY 27.
NSEShareholders meetingResults17 Jul 2026
Jupiter Life Line Hospitals Limited
Shareholders meeting
Jupiter Life Line Hospitals Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on July 17, 2026, and informed the Exchange regarding voting results.
NSERecord DateBonus/Split17 Jul 2026
Jupiter Life Line Hospitals Limited
Record Date
Jupiter Life Line Hospitals Limited has fixed July 24, 2026, as the Record Date for determining the eligibility of equity shareholders entitled to the sub-division/stock split of the Company's equity shares. Each equity share having a face value of ₹10 will be sub-divided/split into 5 equity shares each fully paid up having a face value of ₹ 2.
NSEShareholders meetingResults17 Jul 2026
Jupiter Life Line Hospitals Limited
Shareholders meeting
Jupiter Life Line Hospitals Limited held its 24th Annual General Meeting on July 17, 2026, through video conferencing. The meeting was attended by 48 members, including promoters and public shareholders. The company provided e-voting facilities for shareholders to participate in the meeting. The meeting commenced at 11:00 A.M. and concluded at 11:33 A.M. The company's financial statements, auditor's report, and director's report were presented and taken as read with the consent of the members.
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory6 Jul 2026
Jupiter Life Line Hospitals Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jupiter Life Line Hospitals Limited has informed the Exchange about Certificate 74(5) under SEBI (Depositories and Participants) Regulations, 2018, indicating that the company's entire holding is in Demat form for the quarter ended June 30, 2026, with no rematerialisation requests received during the period.
NSEGeneral Updates29 Jun 2026
Jupiter Life Line Hospitals Limited
General Updates
Jupiter Life Line Hospitals Limited has informed the Exchange regarding the dispatch of a letter to shareholders with a weblink to access the AGM notice and annual report for the FY 2025-26.
NSECopy of Newspaper PublicationResults25 Jun 2026
Jupiter Life Line Hospitals Limited
Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited has informed the Exchange about the completion of dispatch of electronic copies of Annual Report for the Financial Year 2025-26 along with the Notice of the 24th AGM of the Company, scheduled to be held on Friday, July 17, 2026 through VC/OAVM.
NSETrading Window25 Jun 2026
Jupiter Life Line Hospitals Limited
Trading Window
Jupiter Life Line Hospitals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in the securities of the Company will remain closed for all the Designated Person of the Company and their Immediate Relatives from July 1, 2026, till 48 hours from the declaration of the Unaudited Financial Results (Standalone & Consolidated) of the Company to the Stock Exchanges for the quarter ending on June 30, 2026.
NSEShareholders meeting▲ PositiveBonus/Split22 Jun 2026
Jupiter Life Line Hospitals Limited
Shareholders meeting
Jupiter Life Line Hospitals Limited announced its 24th Annual General Meeting (AGM) for July 17, 2026. Key agenda items include the adoption of audited standalone and consolidated financial statements for FY26. Shareholders will also vote on the re-appointment of Dr. Ajay Thakker as a Director, and a change in his designation from Chairman & Managing Director to Chairman & Whole Time Director for a five-year term, with associated remuneration approval. Crucially, the AGM will consider a stock split to subdivide each existing equity share of face value ₹10 into five equity shares, which is positive for liquidity.
NSECopy of Newspaper Publication19 Jun 2026
Jupiter Life Line Hospitals Limited
Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited announced the newspaper publication regarding its 24th Annual General Meeting (AGM). The AGM is scheduled to be held virtually on Friday, July 17, 2026, at 11:00 AM IST, via Video Conference (VC) / Other Audio-Visual Means (OAVM). This intimation, published in compliance with SEBI regulations, serves to inform shareholders about the upcoming mandatory corporate event. Investors should note the date and virtual format, as AGMs typically involve key discussions, approval of financial results, and resolutions important for the company's governance.